Resting‐state connectivity predicts levodopa‐induced dyskinesias in Parkinson's disease
暂无分享,去创建一个
Hartwig R. Siebner | Kristoffer Hougaard Madsen | Kristoffer H. Madsen | H. Siebner | D. Herz | A. Løkkegaard | B. N. Haagensen | Damian M. Herz | Brian N. Haagensen | Annemette Løkkegaard | Silas H. Nielsen | S. Nielsen | B. Haagensen
[1] P. Redgrave,et al. Functional properties of the basal ganglia's re-entrant loop architecture: selection and reinforcement , 2011, Neuroscience.
[2] P. Calabresi,et al. Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap , 2010, The Lancet Neurology.
[3] David Eidelberg,et al. Metabolic brain networks in translational neurology: Concepts and applications , 2012, Annals of neurology.
[4] J. Rothwell,et al. Abnormal bidirectional plasticity-like effects in Parkinson's disease. , 2011, Brain : a journal of neurology.
[5] W. K. Simmons,et al. Circular analysis in systems neuroscience: the dangers of double dipping , 2009, Nature Neuroscience.
[6] E. Bézard,et al. Basal Ganglia Circuits Underlying the Pathophysiology of Levodopa-Induced Dyskinesia , 2010, Front. Neuroanat..
[7] L. Grégoire,et al. Relevance of the MPTP primate model in the study of dyskinesia priming mechanisms. , 2004, Parkinsonism & related disorders.
[8] Hartwig R. Siebner,et al. The motor system and its disorders , 2012, NeuroImage.
[9] C. Kennard,et al. Functional role of the supplementary and pre-supplementary motor areas , 2008, Nature Reviews Neuroscience.
[10] S. Eickhoff,et al. Functional neuroimaging of motor control in parkinson's disease: A meta‐analysis , 2014, Human brain mapping.
[11] P. Cortelli,et al. Pharmacodynamic modeling of oral levodopa , 1993, Neurology.
[12] A. E. Lang,et al. Breast cancer at site of implanted vagus nerve stimulator , 2007, Neurology.
[13] A. Dale,et al. Cortical Surface-Based Analysis II: Inflation, Flattening, and a Surface-Based Coordinate System , 1999, NeuroImage.
[14] Marianna Amboni,et al. The modern pre-levodopa era of Parkinson’s disease: insights into motor complications from sub-Saharan Africa , 2014, Brain : a journal of neurology.
[15] T. Robbins,et al. A role for mesencephalic dopamine in activation: commentary on Berridge (2006) , 2007, Psychopharmacology.
[16] Neeraj Kumar,et al. Levodopa-associated dyskinesia risk among Parkinson disease patients in Olmsted County, Minnesota, 1976-1990. , 2006, Archives of neurology.
[17] B. Forstmann,et al. Neurocognitive mechanisms of action control: resisting the call of the Sirens. , 2011, Wiley interdisciplinary reviews. Cognitive science.
[18] A. Cerasa,et al. Prefrontal thickening in PD with levodopa-induced dyskinesias: new evidence from cortical thickness measurement. , 2013, Parkinsonism & related disorders.
[19] M. Cenci,et al. Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications , 2014, Front. Neurol..
[20] Francesca Morgante,et al. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias. , 2006, Brain : a journal of neurology.
[21] J. Nutt,et al. Effect of brief levodopa holidays on the short‐duration response to levodopa , 1994, Neurology.
[22] A. Aron. From Reactive to Proactive and Selective Control: Developing a Richer Model for Stopping Inappropriate Responses , 2011, Biological Psychiatry.
[23] Hartwig R. Siebner,et al. Abnormal dopaminergic modulation of striato-cortical networks underlies levodopa-induced dyskinesias in humans , 2015, Brain : a journal of neurology.
[24] Hartwig R. Siebner,et al. The acute brain response to levodopa heralds dyskinesias in Parkinson disease , 2014, Annals of neurology.
[25] Joseph Jankovic,et al. Motor fluctuations and dyskinesias in Parkinson's disease: Clinical manifestations , 2005, Movement disorders : official journal of the Movement Disorder Society.
[26] P. Cortelli,et al. Response to a standard oral levodopa test in parkinsonian patients with and without motor fluctuations. , 1990, Clinical neuropharmacology.
[27] C. Clarke,et al. Systematic review of levodopa dose equivalency reporting in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.
[28] Antonio Cerasa,et al. A network centred on the inferior frontal cortex is critically involved in levodopa-induced dyskinesias. , 2015, Brain : a journal of neurology.
[29] M. Fox,et al. Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging , 2007, Nature Reviews Neuroscience.
[30] N H Holford,et al. The response to levodopa in parkinson's disease: Imposing pharmacological law and order , 1996, Annals of neurology.
[31] J. Rothwell,et al. Repetitive transcranial magnetic stimulation for levodopa‐induced dyskinesias in Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.
[32] Yen F. Tai,et al. Clinical correlates of levodopa-induced dopamine release in Parkinson disease , 2006, Neurology.
[33] Nicola Filippini,et al. Functional connectivity in the basal ganglia network differentiates PD patients from controls , 2014, Neurology.
[34] Anders M. Dale,et al. Cortical Surface-Based Analysis I. Segmentation and Surface Reconstruction , 1999, NeuroImage.
[35] N. Tzourio-Mazoyer,et al. Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.
[36] Antonio Cerasa,et al. Increased prefrontal volume in PD with levodopa‐induced dyskinesias: A voxel‐based morphometry study , 2011, Movement disorders : official journal of the Movement Disorder Society.
[37] Ilya M. Veer,et al. The impact of “physiological correction” on functional connectivity analysis of pharmacological resting state fMRI , 2013, NeuroImage.
[38] Viviana Versace,et al. Low frequency rTMS of the SMA transiently ameliorates peak-dose LID in Parkinson’s disease , 2006, Clinical Neurophysiology.
[39] Antonio Cerasa,et al. Prefrontal alterations in Parkinson's disease with levodopa‐induced dyskinesia during fMRI motor task , 2012, Movement disorders : official journal of the Movement Disorder Society.
[40] Vesna Sossi,et al. Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias. , 2004, Brain : a journal of neurology.
[41] Anders M. Dale,et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest , 2006, NeuroImage.
[42] C Caltagirone,et al. rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease , 2005, Neurology.
[43] A. Quattrone,et al. Long‐duration response to levodopa influences the pharmacodynamics of short‐duration response in Parkinson's disease , 1997, Annals of neurology.
[44] Gilberto Fisone,et al. Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease , 2015, Progress in Neurobiology.